CEACAM5 and neoplasm: The aim of the present study was to explore the prognostic information of serum CEA and CA 19-9 in patients with mCRC, especially as related to RAS and BRAF mutation status, and with emphasis on CA 19-9 in patients with BRAF-mutant tumours.